Obamacare Premiums In California May Rise 8 Percent Next Year, State Predicts
The projected  increase in premiums is expected to draw national attention in an election year -- especially from foes of the Affordable Care Act.
Chad Terhune
Chad Terhune was a senior correspondent for Ñî¹óåú´«Ã½Ò•îl Health News until November 2018.
Showing 81 - 96 of 96
-
-
FDA Retreats From Recall Of Scope-Cleaning Machines Tied To Outbreaks
After a wave of sometimes-deadly superbug infections, the agency last year ordered a recall of Custom Ultrasonics machines used to disinfect medical scopes. Now, with little explanation, it is backing off.
By Chad Terhune -
Tainted Scope Infections Far Exceed Earlier Estimates
House panel concludes inquiry on superbug outbreaks; one member prepares legislation “to make sure these situations don’t happen again."
By Chad Terhune -
Major Employers Decry Sutter Health’s Tactics In Dispute Over Prices
Sutter Health, with dominant market share in Northern California, is insisting that employers sign arbitration agreements or face sharply higher out-of-network rates.
By Chad Terhune -
Device Maker Olympus Hiked Prices For Scopes As Superbug Infections Spread
The device manufacturer had a close relationship with Ronald Reagan UCLA Medical Center in Los Angeles — until its scopes were linked to infections and the company raised the price for new ones by 28 percent.
By Chad Terhune and Melody Petersen -
Hackers Seek Ransom From Two More California Hospitals
A malware attack against two Prime Healthcare hospitals in South California, which federal authorities are investigating, comes soon after a case in which hackers demanded ransom from a Los Angeles hospital.
By Chad Terhune -
California Insurance Marketplace Wants To Kick Out Poor-Performing Hospitals
Providers and insurers are balking at a Covered California proposal to eject hospitals with inordinately high costs and low quality from its networks.
By Chad Terhune -
Retail Clinics Add Convenience But Also Hike Costs, Study Finds
Researchers say the clinics tucked in stores and pharmacies lead patients to seek more medical attention than they otherwise would for minor ailments.Â
By Chad Terhune -
Leading Scope Maker Olympus Agrees To Hefty Settlement In Kickback Cases
The company will pay $646 million to end civil and criminal probes. Olympus’ leaders acknowledge responsibility for ‘past conduct’ they say was inconsistent with the firm’s values.
By Chad Terhune -
Aetna CEO Answers Burwell’s Call, Vows Support For Exchanges Amid Losses
But Mark Bertolini wants the country’s marketplaces to better serve young people, who define
healthy as “looking good in their underwear.â€By Chad Terhune -
Urging Openness About Superbug Infections, Doctor Omits Cases In Own Hospital
In a respected medical journal, a specialist advises colleagues on protecting patients but doesn’t mention potential infections from a contaminated scope at his Philadelphia cancer center.
By Chad Terhune -
California Marketplace May Require Insurers To Pay Agent Commissions
Covered California’s Executive Director Peter Lee said the measure is needed to keep insurers from slicing commissions to avoid enrolling the sickest patients.
By Chad Terhune -
Blue Shield Top Choice On California Exchange
Anthem sign-ups are trailing, and UnitedHealth and newcomer Oscar are playing a minor role in coverage thus far, according to unofficial reports.
By Chad Terhune -
Head Of California Exchange Scolds UnitedHealth For Blaming Woes On Obamacare
Peter Lee, executive director of Covered California, says the giant insurer’s complaints about ACA exchanges are “total spin and unanchored in reality.â€
By Chad Terhune -
A Last-Minute Reprieve For Some Consumers On California Exchange
Faced with the possibility of a tax penalty, many people scrambled to enroll, and the exchange extended the deadline for those who officially started the process as of Jan. 31. Â
By Chad Terhune and Barbara Feder Ostrov -
Reforming Federal Oversight Of Medical Devices Won’t Be Easy
Despite dozens of infections from medical scopes, an agreement on how to fix the FDA’s flawed regulation of the device industry remains elusive.
By Chad Terhune
Sign Up For Our Newsletter
Stay informed by signing up for the Morning Briefing and other emails: